TTK and malignant colon neoplasm: It has been reported that specific inhibitors of TTK, AZ3146 and MPI‐0479605, effectively have been described to inhibit proliferation of hct‐116 colon cancer cells, indicating that TTK is involved in tumor formation [17, 18, 19].